0 results for 'Janssen Biotech, Inc.'
Phila. Mass Tort Over Janssen Bladder Drug Winds Down Without Bellwether Trial
The first trial in the mass tort had been scheduled to begin Monday, but most of the program's cases were resolved through confidential settlements in the last six months, according to Kline & Specter partner Tobi Millrood, who serves as plaintiffs liaison counsel in the matter.
New Name or Not, Johnson & Johnson Can't Escape Talc Damages
"In other words, regardless of Johnson & Johnson trying to bankrupt their subsidiary, the company that has the assets is ultimately responsible under New Jersey law," Christopher Placitella, who represents plaintiffs in the asbestos litigation, said.
Litigator of the Week Runners-Up and Shout Outs
Patterson Belknap litigators got a ruling from a federal judge in New Jersey preserving patent protection for Janssen's Invega Trinza, an antipsychotic drug which generates about $600 million in annual sales in the U.S.
Good News for Janssen: Mylan Not Allowed to Reproduce Its Schizophrenia Drug
The judge rejected Mylan's claim that the 693 patent was invalid based on obviousness, meaning that a person of ordinary skill in the art could have formulated the patent's claims using publicly available information.
Law Journal Press | Digital Book
State Antitrust Law
Authors: William T. Lifland
View this Book
View more book results for the query "Janssen Biotech, Inc."
Judge Enters Final Approval of $25M Drug Antitrust Class Action Settlement, $7M in Attorney Fees
U.S. District Judge Karen Marston granted the plaintiff's motion for approval Wednesday, which also included an award of $7 million in attorney fees and $2.3 million in costs.Another Pharmacy Pays: Walmart's $3.1B Agreement Adds to Opioid Coffer
Walmart Inc. agreed to pay $3.1 billion to resolve thousands of lawsuits by cities, counties, Native American tribes and states alleging its pharmacists failed to regulate opioid prescriptions, leading to a public health crisis in their communities.
CVS, Walgreens Pay $10B to Resolve Thousands of Opioid Lawsuits
The agreements in principle, announced on Wednesday, are dependent on the participation of cities, counties and states suing the pharmacies over the opioid crisis.
Lawyers Got Billions From Opioid Companies, But Legal Fight Far From Over
Drug companies settled opioid lawsuits for billions of dollars this year, and some filed for bankruptcy, but several closely watched appeals are coming up, and, for some defendants, such as pharmacies, the fight has just begun.
West Virginia Judge Rules for Drug Distributors in Opioid Case
U.S. District Judge David Faber, in a bench trial that concluded last year in the Southern District of West Virginia, sided with distributors McKesson, Cardinal Health and AmerisourceBergen in a 184-page decision about the opioid crisis.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Andy Goldberg, Laner Muchin Managing Partner 1 minute read
- Legal Speak at Legalweek 2024: Priori CEO and Co-Founder Basha Rubin; Shook, Hardy & Bacon Partner Patrick Oot 1 minute read
Resources
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now